Table 2.
Medical data of HIV-infected women with PPIUDs (n = 64)
| Features | Number (N = 64) | Percentage (%) |
|---|---|---|
| Time of HIV testing | ||
| Before the current pregnancy | 34 | 53.1 |
| During the current pregnancy | 24 | 37.5 |
| At the maternity hospital | 6 | 9.4 |
| Antiretroviral therapy | ||
| Yes | 55 | 85.9 |
| No | 9 | 14.1 |
| CD4 count (elements/ml) | ||
| 200–349 | 7 | 10.9 |
| ≥ 350 | 45 | 70.3 |
| Unspecified | 12 | 18.8 |
| Mode of admission | ||
| Evacuated | 35 | 54.7 |
| Followed up in the department | 29 | 45.3 |
| Time of counseling for PPIUD | ||
| During prenatal consultations | 15 | 23.4 |
| In labor lag phase | 48 | 75.0 |
| Immediate postpartum | 1 | 1.6 |
| Time of insertion of PPIUD | ||
| Post-placental | 14 | 21.9 |
| Immediate postpartum | 8 | 12.5 |
| During cesarean section | 42 | 65.6 |
| Duration of follow-up | ||
| 8 weeks | 25 | 60.9 |
| ≥ 9 weeks | 39 | 39.1 |